AzTrials
AzTrials

HIVSNSUSNCT07414459

Combining Social Network Strategies and Routine Substance Use Screening

A study testing Substance use disorder screening and Social network intervention in people with HIV and Substance Use Disorder (SUD), run by University of California, San Diego at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

This study aims to improve health care for people who may have HIV or substance use disorders by bringing two services to a large community health center in Chicago. First, the clinic will begin offering routine screening for substance use to all patients. Read more about this study

Who is it for?
Ages 18 years and older, men only
Conditions the study is for
HIV, Substance Use Disorder (SUD)
What is being tested?
Substance use disorder screening and Social network intervention
Could I receive a placebo?
No, everyone receives an active treatment
How many people
500 participants
Where
1 siteUnited States
Study dates
31 Jul 2026to Apr 2029
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Men only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Assigned male sex at birth
  • Has sex with men
  • Speaks English or Spanish

Who cannot join

  • Institutionalized individuals
  • Women
  • Non-Hispanic whites

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Britt Skaathun, PhD contact

619-543-5011

bskaathun@health.ucsd.edu

Nicole Carter, MPH contact

619-471-0796

nscarter@health.ucsd.edu

United States1 site
  • Howard Brown Health

    Chicago, Illinois, 60657

    Aniruddha (Anu) Hazra, MD, 773-388-1600, ahazra2@bsd.uchicago.edu

Other trials in United States

About this study

This study aims to improve health care for people who may have HIV or substance use disorders by bringing two services to a large community health center in Chicago. First, the clinic will begin offering routine screening for substance use to all patients. Second, the study will offer a social network-based program that helps people identify friends or partners who may need support and link them to care. The goal is to help more people learn their HIV status, reduce HIV levels in the community, and connect people with substance use treatment when needed. The study will also look at how well these services can be added into everyday clinic practice and what is needed to keep them going over time.

Read the detailed description

This project will take place in a network of federally qualified health centers that serves communities in Chicago that experience some of the highest rates of new HIV infections. The study has two main parts: Routine Substance Use Screening and a Social Network Intervention (SNI).

Routine screening at the clinics will introduce a consistent, standardized way to ask patients about substance use during regular visits. Patients who screen positive will be offered help, referrals, and follow-up services.

The social network intervention asks patients to think about people in their social networks (such as partners, friends, or peers) who may have untreated HIV, may have fallen out of care, or may have substance use concerns. Participants will receive support and tools to help connect people in their network to HIV testing, care, and treatment or substance use services at these clinics.

Together, these activities aim to:

  • Identify people who have HIV but are not in care
  • Reduce HIV viral load levels in the community
  • Identify people with substance use disorders and link them to treatment
  • Improve access to supportive services in the community

The study will also examine how easy or hard it is for clinics to use these two strategies in everyday practice. Researchers will gather feedback from clinic staff and patients to understand what helps or gets in the way of using these services in the long term. The goal is to create a package of tools and processes that other clinics can adopt in the future.

Being tested
Substance use disorder screening, Social network intervention
Keywords
social networks, HIV, substance use disorder, HIV testing, HIV prevention, harm reduction, social stigma, programs, testing, treatment, mental health, community clinic, intervention, color, Chicago, drug abuse, addiction
Medical subject headings
Substance-Related Disorders, Harm Reduction, Social Stigma, Psychological Well-Being, Behavior, Addictive

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Substance use disorder screeningBehavioural

    Implement a routine SUD screening at the FQHC.

  • Social network interventionBehavioural

    Social network intervention (SNI) to identify individuals who are viremic, have SUD, or both and link them to harm reduction and HIV continuum of care services. There are three main activities that make up the SNI: 1) recruiting, screening, and interviewing "index participants"; 2) training the index participants to recruit others; 3) screening and interviewing persons who present a valid recruitment voucher given to them by an index participant.

Study groups in NCT07414459
Study groupRoleWhat they receive
Routine Substance Use disorder (SUD) screeningActive comparatorA routine screener for substance use disorder (SUD) will be added to the standard of care at HBH regardless of HIV status or demographic characteristics.
Receives: Behavioral: Substance use disorder screening
Social Network Intervention (SNI)ExperimentalIn addition to the routine screener for SUD, this arm will receive the Social Network Intervention (SNI), which include the following elements: 1. recruiting, screening, and interviewing "index participants"; 2. training the index participants to recruit others; 3. screening and interviewing persons who present a valid recruitment voucher given to them by an index participant; and 4. training recruits to recruit others.
Receives: Behavioral: Substance use disorder screening; Behavioral: Social network intervention

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of Substance Use Disorder (SUD) Detection

    The number and proportion of patients who screen positive for substance use disorder using the routine SUD screening tool (NIDA Quick Screen) compared with the number identified through existing electronic medical record (EMR) documentation. This outcome measures whether routine screening increases the detection of individuals with possible SUD.

    Measured: Baseline through 24 months

  2. Number of Individuals Identified as Viremic and/or Having SUD Through the Social Network Intervention (SNI)

    The number of people identified through the Social Network Intervention who have unsuppressed HIV (viremia), substance use disorder, or both. This will be compared to a functional control group (new or re-engaged clinic patients during the same time period) to determine whether the SNI is more effective at finding high-priority individuals needing care.

    Measured: Baseline through 24 months

  3. Linkage to HIV Care or Substance Use Services

    The proportion of individuals identified through SUD screening or the SNI who successfully link to harm reduction, HIV care, or substance use treatment services. This outcome assesses early engagement in care following identification.

    Measured: Baseline through 24 months

Secondary outcomes (8)
  1. Viral Suppression Among Individuals Identified Through Screening or SNI

    The proportion of people identified with HIV who achieve viral suppression after being linked to care. This measures the downstream impact of improved identification and engagement.

    Measured: Baseline through 24 months

  2. Time to Linkage to HIV Care or Substance Use Services

    The number of days from identification (via SUD screen or SNI) to the first attended HIV care appointment, harm reduction service, or substance use treatment visit.

    Measured: Baseline through 24 months

  3. Number of New HIV Diagnoses Identified Through the SNI

    The number of individuals identified by SNI participants who test positive for HIV and were previously undiagnosed.

    Measured: Baseline through 24 months

  4. Substance Use Treatment Initiation

    The proportion of people identified with SUD who initiate counseling, medication-assisted treatment, or other substance use services.

    Measured: Baseline through 24 months

  5. Re-engagement in HIV Care

    The number and proportion of individuals previously out of care for ≥6 months who return for at least one HIV medical visit after identification.

    Measured: Baseline through 24 months

  6. Acceptability of SUD Screening and the SNI

    Acceptability scores based on surveys and interviews with clinic staff and participants, assessing satisfaction, perceived burden, and overall fit within the clinical setting.

    Measured: Measured at Months 6, 12, 18, and 24

  7. Feasibility of Implementing the SUD Screener and SNI

    Assessment of whether the interventions can be carried out in the clinic as intended, measured by workflow fit, completion rates, and staff-reported ease of implementation.

    Measured: Baseline through 24 months

  8. Sustainability of Screening and SNI Workflows (EPIS: Sustainment Phase)

    Indicators of ongoing use of SUD screening and SNI processes without external study support, including continued staff utilization and workflow integration.

    Measured: Measured at 24 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Feb 2026
  2. Study start31 Jul 2026 (estimated)
  3. Primary completion30 Apr 2028 (estimated)
  4. Study completionApr 2029 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
Viral suppression and SUD reduction will be monitored via chart review and used to parameterize an agent-based model (ABM) examining the potential population-level impact of implementing the SUD screener and SNI across Chicago on the local HIV epidemic. Control data will consist of standard intake data on new patients and patients returning to care at HBH. Standard intake data will be collected corresponding to the same timeframe as the recruitment period for the SNI.
Masking
None (open label)
Enrolment
500 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07414459
Sponsor's protocol ID
813457
Other IDs
R37DA063274
Acronym
SNSUS
Status last verified
Feb 2026
First submitted
9 Feb 2026
Last updated
5 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Proctor E, Silmere H, Raghavan R, Hovmand P, Aarons G, Bunger A, Griffey R, Hensley M. Outcomes for implementation research: conceptual distinctions, measurement challenges, and research agenda. Adm Policy Ment Health. 2011 Mar;38(2):65-76. doi: 10.1007/s10488-010-0319-7.

    PubMed 20957426
  • Aarons GA, Hurlburt M, Horwitz SM. Advancing a conceptual model of evidence-based practice implementation in public service sectors. Adm Policy Ment Health. 2011 Jan;38(1):4-23. doi: 10.1007/s10488-010-0327-7.

    PubMed 21197565
  • Oehler C, Rajagopal A, Songster T, Schmitt J, McNulty M, Schneider J, Pitrak D, Ridgway JP. Partner Notification Services for Patients with Established and New HIV Infection Leads to Diagnosis and Linkage of HIV-Positive Partners. AIDS Behav. 2021 Mar;25(3):809-813. doi: 10.1007/s10461-020-03043-5. Epub 2020 Sep 19.

    PubMed 32949327
  • Cummins B, Johnson K, Schneider JA, Del Vecchio N, Moshiri N, Wertheim JO, Goyal R, Skaathun B. Leveraging social networks for identification of people with HIV who are virally unsuppressed. AIDS. 2024 Feb 1;38(2):245-254. doi: 10.1097/QAD.0000000000003767. Epub 2023 Oct 26.

    PubMed 37890471
  • Skaathun B, Pho MT, Pollack HA, Friedman SR, McNulty MC, Friedman EE, Schmitt J, Pitrak D, Schneider JA. Comparison of effectiveness and cost for different HIV screening strategies implemented at large urban medical centre in the United States. J Int AIDS Soc. 2020 Oct;23(10):e25554. doi: 10.1002/jia2.25554.

    PubMed 33119195
  • Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012 Mar;50(3):217-26. doi: 10.1097/MLR.0b013e3182408812.

    PubMed 22310560
  • McPherson M, Smith-Lovin L, Cook JM. Birds of a Feather: Homophily in Social Networks. Annual Review of Sociology 2001; 27(1): 415-44.

  • Shrader CH, Borquez A, Vasylyeva TI, Chaillon A, Artamanova I, Harvey-Vera A, Vera CF, Rangel G, Strathdee SA, Skaathun B. Network-level HIV risk norms are associated with individual-level HIV risk and harm reduction behaviors among people who inject drugs: a latent profile analysis. AIDS Behav. 2023 Feb;27(2):484-495. doi: 10.1007/s10461-022-03783-6. Epub 2022 Aug 8.

    PubMed 35939177
  • Nikolopoulos GK, Pavlitina E, Muth SQ, Schneider J, Psichogiou M, Williams LD, Paraskevis D, Sypsa V, Magiorkinis G, Smyrnov P, Korobchuk A, Vasylyeva TI, Skaathun B, Malliori M, Kafetzopoulos E, Hatzakis A, Friedman SR. A network intervention that locates and intervenes with recently HIV-infected persons: The Transmission Reduction Intervention Project (TRIP). Sci Rep. 2016 Dec 5;6:38100. doi: 10.1038/srep38100.

    PubMed 27917890
  • Morgan E, Skaathun B, Nikolopoulos GK, Paraskevis D, Williams LD, Smyrnov P, Friedman SR, Schneider JA. A Network Intervention to Locate Newly HIV Infected Persons Within MSM Networks in Chicago. AIDS Behav. 2019 Jan;23(1):15-20. doi: 10.1007/s10461-018-2202-6.

    PubMed 29951972
  • Centers for Disease Control and Prevention (CDC). Use of social networks to identify persons with undiagnosed HIV infection--seven U.S. cities, October 2003-September 2004. MMWR Morb Mortal Wkly Rep. 2005 Jun 24;54(24):601-5.

    PubMed 15973240
  • Jones E, Rieckmann T. Substance Use Disorder Screening Capacity Lags Behind Depression Screening Capacity in Community Health Centers. Journal of Drug Issues 2017.

  • Dawson-Rose C, Draughon JE, Zepf R, Cuca YP, Huang E, Freeborn K, Lum PJ. Prevalence of Substance Use in an HIV Primary Care Safety Net Clinic: A Call for Screening. J Assoc Nurses AIDS Care. 2017 Mar-Apr;28(2):238-249. doi: 10.1016/j.jana.2015.12.001. Epub 2015 Dec 11.

    PubMed 26763795
  • Lucas GM, Gebo KA, Chaisson RE, Moore RD. Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic. AIDS. 2002 Mar 29;16(5):767-74. doi: 10.1097/00002030-200203290-00012.

    PubMed 11964533
  • Grov C, Westmoreland D, Morrison C, Carrico AW, Nash D. The Crisis We Are Not Talking About: One-in-Three Annual HIV Seroconversions Among Sexual and Gender Minorities Were Persistent Methamphetamine Users. J Acquir Immune Defic Syndr. 2020 Nov 1;85(3):272-279. doi: 10.1097/QAI.0000000000002461.

    PubMed 32740370

Questions about this trial

What is this clinical trial studying?

A study testing Substance use disorder screening and Social network intervention in people with HIV and Substance Use Disorder (SUD), run by University of California, San Diego at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Britt Skaathun, PhD (619-543-5011, bskaathun@health.ucsd.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of Substance Use Disorder (SUD) Detection (time frame: Baseline through 24 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT07414459, which also lists 39 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in